Study Tests Minimally Invasive Treatment for Barrett’s Esophagus

Perelman School of Medicine conducted a study of endoluminal therapy, an endoscopy-based treatment, on patients with Barrett’s esophagus or in the early stages of cancer and found that neoplasia was eliminated in 95 percent of patients, according to a Gastrointestinal Endoscopy Journal article.

Advertisement

The retrospective cohort study was conducted with 166 patients and found that endoluminal therapy for patients with Barrett’s esophagus with high grade dysplasia or early cancer was highly successful, but a third of patients experienced a reoccurrence of intestinal metaplasia.

More Articles on Gastroenterology:
Study Evaluates Efficacy of LINX Magnetic Device for Reflux Disease
Four-Day International GI Conference Ends
Review: Resistant Starch Could Help Body Resist Colorectal Cancer

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.